◎Group business policy & important production and marketing policies:

(一 ) Business policy

(1) 1. Strive for core product agents (such as nephrology, dentistry, cardiology, respiratory and thoracic surgery, spine surgery, sleep disorders, blood purification, intensive care medical care, long-term home care, pharmaceuticals and functional nutrition, etc.), Establish high-quality medical materials and pharmaceutical supply platform sales channels.
(2) 2. Actively expand the market in mainland China and Southeast Asia.

(二) Important production and marketing policies

1.Continue to expand the domestic medical industry
(1)Continue to develop sales in the fields of hemodialysis, Dentistry materials, medical catheters, respiratory therapy, anesthesia consumables, first aid consumables/equipment, home health care equipment, nutritional products and other fields.
(2)Invest in new medical product areas.
2.Expand sales in overseas markets: short- and medium-term plans
(1) Actively expand the Dentistry material market sales in China.
(2) Lay out the hemodialysis market sales in Southeast Asia.
Improve the autonomy of market channels
Through cooperation alliances with medical institutions, operation management consulting business and BOT cooperation model, we gain control over the channel.
Actively expand cooperation with original manufacturers
Cooperate with original manufacturers and adopt OEM or ODM methods to provide products that meet market demand and expand overseas market sales areas.